Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KG.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KG.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDJEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDJECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDJECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDJEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDJEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDJENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.3.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CR.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
CR.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CR.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CR.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BV.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BV.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BV.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BV.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BV.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.4.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.4.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.4.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.4.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used